[1] | Zhaohui BAI, Yongping YANG, Li YANG, Xingshun QI. An excerpt of use of albumin infusion for cirrhosis-related complications: an international position statement in 2022[J]. Journal of Clinical Hepatology, 2023, 39(8): 1817-1818. doi: 10.3969/j.issn.1001-5256.2023.08.008 |
[2] | Qian HUANG, Yan YANG, Rui ZENG, Menglin YAO, Qin SUN. Regulation of liver fibrosis by matrix metalloproteinase/tissue inhibitor of metalloproteinase and research advances in related therapeutic drugs[J]. Journal of Clinical Hepatology, 2022, 38(6): 1420-1425. doi: 10.3969/j.issn.1001-5256.2022.06.042 |
[3] | Zhang HongHai, Sun Yu, Liu Fang, Xie Li, Qiao LuXin, Chen DeXi, Yin JiMing. Determination and clinical significance of plasma matrix metalloproteinase in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(4): 825-829. doi: 10.3969/j.issn.1001-5256.2019.04.023 |
[5] | Hou LiYan, Jia RuJiang, Ren LiBing, Yang GengWu. Effect of interference of Sema4D expression on cell biological characteristics in pancreatic cancer[J]. Journal of Clinical Hepatology, 2018, 34(2): 350-353. doi: 10.3969/j.issn.1001-5256.2018.02.026 |
[6] | Ge HongYan, Zhang ShiHua. Research advances in association between matrix metalloproteinases and liver fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(3): 563-566. doi: 10.3969/j.issn.1001-5256.2017.03.037 |
[8] | Shi JuanJuan, Yang Ning, Zhang Xin, Wu FengPing, Li Mei, Gao Ning, Jia XiaoLi, Zhai Song, Dang ShuangSuo. Effect of prohibitin on hepatitis C virus replication[J]. Journal of Clinical Hepatology, 2016, 32(9): 1729-1733. doi: 10.3969/j.issn.1001-5256.2016.09.019 |
[9] | Wu Fan, Yi ZaiFeng, Tian DeYing. Construction of specific interference vector and lentiviral packaging for SMAC gene in mice[J]. Journal of Clinical Hepatology, 2014, 30(5): 442-445. doi: 10.3969/j.issn.1001-5256.2014.05.015 |
[10] | Zheng SuJun, Xing XinYue, Wu JuShan, Wang ShiMei, Zhang Ying, Han YuanPing, Yu Hao, Chen Yu, Liu Mei, Duan ZhongPing. ShRNA targeted to rat Smad3 decreases the profibrosis role of TGFβ1 in HSC-T6 cells[J]. Journal of Clinical Hepatology, 2012, 28(4): 289-295. |
[11] | Wang YingChun, Liu YanFang, Zhu RuiPing, Song XinXin, Li XiaoHuan. Expression of histone deacetylase 1 and matrix metalloproteinase-2 in hepatocellular carcinoma and its significance[J]. Journal of Clinical Hepatology, 2012, 28(4): 276-278+288. |
[12] | Chen Peng, Zheng SuJun, Wang ShiMei, Zhang JianJun, Xing XinYue, Zhang Ying, Liu Mei, Duan ZhongPing. Selection of siRNA and construction of recombinant lentivirus expressing shRNA targeting rat Smad3 gene[J]. Journal of Clinical Hepatology, 2011, 27(5): 533-537. |
[13] | Mao XiaoRong, Xue Miao, Chen Hong. The application prospect of RNA interference in the treatment of hepatic fibrosis [J]. Journal of Clinical Hepatology, 2010, 26(4): 436-437. |
[14] | Jiang Ying, A YiTuLa. Expression of TGFβ1、TIMP1 in liver cirrhosis and pathological significance[J]. Journal of Clinical Hepatology, 2009, 25(1): 39-41. |
[17] | Shao Ying. The expression of MMP-9 and TIMP-1 in HCC and clinical significance[J]. Journal of Clinical Hepatology, 2006, 22(1): 47-48. |
[18] | Zhu ZhengYan, Du Zhi, Wang YiJun, Zhang Wen, Sun BaoCun. The Study on Relationship between E-cadherin, MMP-2 and MMP-9' expressions and the prognosis of hepatolellular carcinoma.[J]. Journal of Clinical Hepatology, 2002, 18(4): 235-236. |